Intellectual Property Strategy. Within three months following the Effective Date, the Company will adopt an intellectual property strategy reasonably acceptable to LVP, and provide a written summary of the strategy to the Placement Agent.
Intellectual Property Strategy. (a) Hospira shall, at Hospira’s sole cost and expense, have sole control over the creation and implementation of any strategy related to any Actions (including inter partes reviews and declaratory judgments) with respect to Patents of Third Parties, in each case with respect to the development, manufacture, launch (including obtaining Regulatory Approval), marketing, commercialization and sale of Product in all markets, including the sole right to determine (i) when and if to initiate any such Action with respect to any Third Party’s Patent (other than as covered by the terms of Section 6.6), including by way of example any nullity or invalidity case brought against any Third Party’s Patents specific to the development, manufacture, launch, marketing, commercialization and sale of Product; (ii) the earliest date on which Product will be manufactured, imported, used, offered for sale and/or sold in any given country; (iii) when and how to change the development or manufacture of Product (provided that any modification to the Manufacturing Strain shall be subject to Section 3.1(e)) in order to minimize the effect of any Third Party’s Intellectual Property from the development, manufacture, launch, marketing, commercialization and sale of Product, such as the institution of circumvention strategies or the proactive seeking of a license from a Third Party; (iv) the appropriate course of action in the event any Third Party commences an Action alleging that Product or the development, manufacture, launch, marketing, commercialization or sale of Product infringes any Intellectual Property of such Third Party (other than as covered by the terms of Section 6.5), including assuming and controlling the defense of any such Action; and (v) when and if to settle, compromise or consent to any judgment with respect to any Action with respect to any Third Party’s Intellectual Property; provided, that Hospira shall be required to obtain Pfenex’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed) to the extent the same would likely have a material adverse effect on Pfenex, its Affiliate or their rights (the “IP Strategy”). For clarity, nothing in this Section 6.4 shall limit Pfenex’s right with respect to Actions related to Patents or other Intellectual Property of Third Parties in connection with the development, manufacture, launch (including obtaining Regulatory Approval), marketing, commercialization and sale of products other th...
Intellectual Property Strategy. The Recipient will develop an Intellectual Property (IP) strategy that will be shared with the Minister within six (6) months of the execution date of the Agreement. This strategy will support the creation and retention of Intellectual Property ownership in Canada; include training for employees that increases Intellectual Property educational awareness and identify any planned Intellectual Property training activities; include a plan to commercialize vaccines domestically, including Intellectual Property commercialization activities, such as licensing, and anticipated collaboration activities, if any; and include a current list of Background Intellectual Property. The Recipient agrees to report annually on any changes to this strategy during ***and for a period of *** years thereafter.
Intellectual Property Strategy. The Recipient will develop an Intellectual Property (IP) strategy that will be shared with the Minister within [______] ([______]) months of the Execution Date. This strategy will support the creation, retention and protection of Intellectual Property ownership in Canada; include training for employees that increases Intellectual Property educational awareness and identify any planned Intellectual Property training activities; include a plan to commercialize Resulting Products domestically, including Intellectual Property commercialization activities, such as licensing, and anticipated collaboration activities, if any; and include a current list of Background Intellectual Property. The Recipient agrees to report annually on any changes to this strategy [______]. [Number of months and timeframe omitted as competitively sensitive information.] SIF AGREEMENT NO. 811-513437
Intellectual Property Strategy. The Parties acknowledge the importance of effectively securing and managing the intellectual property relating to Programme Antigens and any Product. The Parties shall, consistent with Clause 9 and Schedule 9, seek to obtain and maintain the broadest patent protection that is commercially reasonable across the Territory, extending this protection through additional filings and the use of supplementary protection certificates where appropriate, and to protect the confidentiality of all Know How relating to the Programme Antigens and any Product.
Intellectual Property Strategy. Within three months after the initial issuance of the Notes, the Company will adopt an intellectual property strategy reasonably acceptable to MDB Capital Group LLC, and provide a detailed written statement of the strategy to the Buyers.
Intellectual Property Strategy. Until twelve (12) months after the Qualifying IPO, the Company will pursue an intellectual property strategy reasonably acceptable to MDB.
Intellectual Property Strategy. The Recipient shall develop an Intellectual Property Strategy (IP), [**] of the Execution Date and [**] if there are any changes to the IP Strategy during the Term. The IP Strategy will [**] and include at least the following elements:
Intellectual Property Strategy. The Recipient shall develop an Intellectual Property strategy (IP Strategy), share it with the Minister within one (1) year of the execution date of the contribution Agreement and report annually if there are any changes to the IP Strategy during the Term. The IP Strategy will support the creation and retention of Intellectual Property ownership in Canada and include at least the following elements:
Intellectual Property Strategy
